Expired
Section
Original release date:
April 6, 2020
Access to this course expires on: October 23, 2022 at 11:59 PM Pacific Time
CME 20.5
Course Description
Diagnostic surgical pathology is a rapidly evolving field, informed
by discoveries in molecular genetics and improvements in tumor
classification. Uterine, hepatic, bone, lymphoma, gastroesophageal and
soft tissue tumor pathology are examples of subspecialty areas that have
made dramatic changes in recent years. Surgical pathologists must
become familiar with recent changes in tumor classification, recently
developed diagnostic markers, recently discovered molecular genetic
alterations and evolving diagnostic criteria for neoplastic and
non-neoplastic disorders in surgical pathology. They must also be
intuitively conversant with relevant differential diagnoses, ordering
appropriate panels of markers and molecular tests, and applying
diagnostic criteria to arrive at specific diagnoses.
The American Registry of Pathology is a non-profit organization founded in 1921 and chartered by Congress to serve the medical scientific communities. ARP Press has been publishing the AFIP Fascicles of Tumor and Non-Tumor Pathology since 1990. ARP
Press provides steep discounts on all its books to make them affordable
to resident and fellow pathologists, and donates frequently to
under-served countries.
Target Audience
Practicing academic and community pathologists, and pathologists-in-training
Learning Objectives
Upon completion of this educational activity, learners will be able to:
Continuing Medical Education
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the United States and Canadian Academy of Pathology and the American Registry of Pathology. The United States and Canadian Academy of Pathology is accredited by the ACCME to provide continuing medical education for physicians.
The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 20.5
AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Beginning in 2021, the American Board of Pathology (ABPath) will no longer require Self-Assessment Modules (SAMs) for Part II Lifelong Learning of the Continuing Certification program. For additional information, visit the
ABPath website.
Disclosures
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. USCAP has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.
The following faculty reported relevant financial relationships: Jason L. Hornick, MD, PhD, Consultant, Eli Lilly, Epizyme
The following faculty reported no relevant financial relationships: Elizabeth A. Montgomery, MD, G. Petur Nielsen, MD, Esther Oliva, MD, Michael Torbenson, MD, Dennis P. O'Malley, MD
The following IM Coordinator who planned and reviewed content for this activity reported no relevant financial relationships: Steven D. Billings, MD
USCAP staff associated with the development of content for this activity reported no relevant financial relationships.
To earn CME credit, all learners must complete the evaluation. View and print your certificate by clicking here.
Buy the entire Interactive Microscopy with Authors of the Fascicles course and get a great discount!
Not A Member? Click Here